Predictions
Lennar Corp. A
Start price
Target price
Perf. (%)
€62.00
15.12.20
15.12.20
-
15.12.21
15.12.21
20.16%
15.03.21
15.03.21
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Higher risks for its business
Atmos Energy Corp.
Start price
Target price
Perf. (%)
€83.00
15.12.20
15.12.20
€88.00
15.12.21
15.12.21
4.82%
16.12.21
16.12.21
Could be worthwhile Investment >10% per year
Lenovo Group Ltd
Start price
Target price
Perf. (%)
€0.71
15.12.20
15.12.20
€1.00
2.04%
17.12.20
17.12.20
Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Fair valuation
Volkswagen AG VZO
Start price
Target price
Perf. (%)
€147.28
15.12.20
15.12.20
€143.00
-0.26%
15.12.20
15.12.20
High valuation
Volkswagen AG VZO
Start price
Target price
Perf. (%)
€146.26
15.12.20
15.12.20
€143.00
0.23%
15.12.20
15.12.20
High valuation
Volkswagen AG VZO
Start price
Target price
Perf. (%)
€145.74
15.12.20
15.12.20
€143.00
0.36%
15.12.20
15.12.20
High valuation
Infineon Technologies AG
Start price
Target price
Perf. (%)
€28.87
15.12.20
15.12.20
-
-0.07%
15.12.20
15.12.20
Known brand
Future proof or reliable business model
Risky Investment
Low dividend yield expected
AngloGold Ashanti Ltd. ADR
Start price
Target price
Perf. (%)
€17.95
15.12.20
15.12.20
-
15.12.21
15.12.21
6.41%
12.01.21
12.01.21
Revenue growth > 30% per year expected
EBIT growth > 30% per year expected
Could be very worthwhile Investment >20% year
Undervalued
AngloGold Ashanti Ltd.
Start price
Target price
Perf. (%)
€17.94
15.12.20
15.12.20
-
15.12.21
15.12.21
7.86%
12.01.21
12.01.21
Revenue growth > 30% per year expected
Rising EBIT margin expected
Could be very worthwhile Investment >20% year
EBIT growth > 30% per year expected
Phio Pharmaceuticals Corp.
Start price
Target price
Perf. (%)
€25.44
14.12.20
14.12.20
€36.00
24.53%
11.01.21
11.01.21
Could be worthwhile Investment >10% per year
Jaguar Health Inc.
Start price
Target price
Perf. (%)
€61.20
14.12.20
14.12.20
€225.00
1282.35%
11.01.21
11.01.21
Could be worthwhile Investment >10% per year
Rubius Therapeutics Inc.
Start price
Target price
Perf. (%)
€7.30
14.12.20
14.12.20
-
14.12.21
14.12.21
169.86%
07.07.21
07.07.21
Probably not worthwhile Investment
Avinger Inc.
Start price
Target price
Perf. (%)
€4.88
14.12.20
14.12.20
€20.00
301.64%
11.01.21
11.01.21
Could be worthwhile Investment >10% per year
ElringKlinger AG
Start price
Target price
Perf. (%)
€14.22
14.12.20
14.12.20
€15.00
2.11%
15.12.20
15.12.20
Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Stable Large shareholder and/or long term investor
TOP Ships Inc.
Start price
Target price
Perf. (%)
€20.80
14.12.20
14.12.20
€40.00
28.85%
11.01.21
11.01.21
Could be very worthwhile Investment >20% year
Atossa Genetics Inc
Start price
Target price
Perf. (%)
€0.72
14.12.20
14.12.20
€2.00
14.12.21
14.12.21
9.69%
11.01.21
11.01.21
Could be worthwhile Investment >10% per year
InVivo Therapeutics Holdings
Start price
Target price
Perf. (%)
€13.00
14.12.20
14.12.20
€25.00
14.12.21
14.12.21
71.15%
11.01.21
11.01.21
Could be worthwhile Investment >10% per year
Nuwellis Inc.
Start price
Target price
Perf. (%)
€6.00
14.12.20
14.12.20
€8.00
14.12.21
14.12.21
6.67%
11.01.21
11.01.21
Could be very worthwhile Investment >20% year
Rubius Therapeutics Inc.
Start price
Target price
Perf. (%)
€8.20
14.12.20
14.12.20
€11.00
14.12.21
14.12.21
15.85%
29.01.21
29.01.21
Could be worthwhile Investment >10% per year
Very capable Management
Good culture
Sustainability is little important
Biocardia Inc.
Start price
Target price
Perf. (%)
€4.53
14.12.20
14.12.20
€5.00
14.12.21
14.12.21
-24.50%
29.01.21
29.01.21
Could be worthwhile Investment >10% per year
Capable Management
Differentiated customer and product portfolio
high free float
Rubius Therapeutics Inc.
Start price
Target price
Perf. (%)
€7.90
14.12.20
14.12.20
€2.00
14.12.21
14.12.21
158.23%
26.06.21
26.06.21
Risky Investment
Revenue decline > 20% expected
EBIT decline > 20% expected
Decining EBIT margin than peer group
CBAK Energy Technology Inc
Start price
Target price
Perf. (%)
€4.06
14.12.20
14.12.20
€4.00
3.94%
16.12.20
16.12.20
Revenue growth >5% per year expected
Future proof or reliable business model
Could be worthwhile Investment >10% per year
Standard Investments for future growth